Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674856 | SCV000800258 | pathogenic | Cockayne syndrome type 1 | 2018-05-29 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics Munich, |
RCV000674856 | SCV004045934 | pathogenic | Cockayne syndrome type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004702307 | SCV005202100 | pathogenic | not provided | 2023-08-09 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect and show that this variant results in a new 28 amino acid C-terminus and premature termination of the CSA protein (Kleppa et al., 2007); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as IVS6-1G>A; This variant is associated with the following publications: (PMID: 25525159, 19894250, 33726816, 17084038) |